#United States #Draper #Ortho Development #Hip Stem #Trivicta

Ortho Development Launches Trivicta® Hip Stem

Ortho Development Corporation, stationed in Draper, Utah, has officially announced the full commercial launch of its latest innovation, the Trivicta® Hip Stem. This implant is a cementless triple-taper femoral component designed specifically for primary total hip arthroplasty and will be accessible to surgeons across the United States through a comprehensive distribution network.

This launch represents a significant milestone for Ortho Development, showcasing the dedication and collaboration that has gone into the product's design and development. Greg Larson, President of Ortho Development, remarked on the importance of Trivicta, noting that early feedback from the market has validated their efforts and the product's refined design capabilities. "Trivicta represents an important milestone for Ortho Development and reflects the collaboration, clinical insights and engineering discipline behind its development and launch," Larson stated.

Enhanced Design and Features

The Trivicta® Hip Stem aims to enhance the hip surgery experience by addressing key challenges faced by surgeons and patients alike. The innovative design incorporates a full 35 μm hydroxyapatite coating over sintered titanium beads. This feature promotes early osteointegration, ultimately aiding in the implant's stability and longevity. Surgeons can choose between standard and extended offset options, ensuring that leg length remains unaffected while providing direct lateralization.

Another advantage of the Trivicta is its progressive neck lengths and refined distal geometry, which cater to various femoral morphologies, promoting anatomical versatility to meet patient-specific needs. The system's refined femoral stem is engineered to support stability, versatility, and efficiency during the surgical process.

A unique hybrid broach system integrates anterior and posterior compaction teeth, designed to preserve bone integrity while facilitating precise implant seating. Additional modular instrumentation and incremental stem sizing aim to streamline surgical preparation, thereby reducing variability and improving efficiency across various surgical approaches.

Positive Clinical Feedback

Surgeons who have utilized the Trivicta Hip Stem in early releases have reported significant clinical benefits. Dr. Justin T. Deen of the Florida Orthopaedic Institute expressed his satisfaction with the new system, stating, "The offset and neck length progression moves through smoothly, and the instrumentation is straightforward to work with. Clinically, I have seen good evidence of ingrowth, and the system has become my primary choice for the large majority of primary hip cases." This positive reaction highlights how the Trivicta can enhance surgical outcomes and patient recovery.

As the demand for reliable and effective orthopedic solutions continues to grow, Ortho Development remains committed to delivering high-quality products and superior service aimed at improving patient mobility and overall quality of life. For more information on the Trivicta® Hip Stem and other offerings, visit Ortho Development's website.

About Ortho Development Corporation

Ortho Development Corporation was founded in 1994 and is dedicated to the design and manufacture of orthopedic implants and surgical instruments, specializing in knee and hip joint replacements. The company prides itself on fostering strong relationships with orthopedic surgeons, distributors, and sales representatives, which has been integral in delivering effective and dependable products. By maintaining a commitment to quality and service, Ortho Development continues to be a trusted name in the orthopedic industry, focused on delivering solutions that help restore mobility and improve patient outcomes.